Persistent Asset Partners LTD Options Holdings

Persistent Asset Partners LTD

  • $145 Billion
  • Q3 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
Altimmune Inc
CALL
$28.8 Million
1.06K
Q3 2025
Reduced 63.44%
Avita Medical Inc
CALL
$22.2 Million
1.46K
Q3 2025
New holding
Apogee Therapeutics Inc
CALL
$28.7 Million
295
Q3 2025
Reduced 18.51%
Editas Medicine Inc
CALL
$27.7 Million
693
Q3 2025
New holding
Scholar Rock Hldg Corp
CALL
$35.5 Million
229
Q3 2025
New holding
Vistagen Therapeutics Inc
CALL
$28.7 Million
231
Q3 2025
New holding
Apple Inc
CALL
$16.1 Million
140
Q3 2025
New holding
Amicus Therapeutics Inc
CALL
$16.7 Million
303
Q1 2025
New holding
Nvidia Corporation
CALL
$16.5 Million
31
Q3 2025
Reduced 94.46%
Spdr S&P 500 ETF Tr
CALL
$15.2 Million
20
Q3 2025
Reduced 83.33%
Sl Green Rlty Corp
CALL
$16.9 Million
90
Q3 2025
New holding
Affirm Hldgs Inc
CALL
$9.26 Million
23
Q3 2025
Reduced 65.15%
Sellas Life Sciences Group I
CALL
$11.6 Million
920
Q2 2025
New holding
Novavax Inc
CALL
$7.78 Million
399
Q3 2025
New holding
Corcept Therapeutics Inc
PUT
$18.4 Million
61
Q3 2025
Reduced 99.95%
Corvus Pharmaceuticals Inc
PUT
$8.27 Million
114
Q3 2025
New holding
Micron Technology Inc
CALL
$13.7 Million
12
Q3 2025
New holding
Jade Biosciences Inc
PUT
$10.2 Million
88
Q3 2025
Reduced 99.29%
Pagaya Technologies LTD
CALL
$8.94 Million
32
Q3 2025
Reduced 87.2%
Acadia Pharmaceuticals Inc
CALL
$11.9 Million
204
Q2 2025
New holding
Interactive Brokers Group In
CALL
$12.3 Million
40
Q3 2025
New holding
Puma Biotechnology Inc
CALL
$8.66 Million
312
Q3 2025
New holding
TLTW
Ishares Tr 20+ Yr Treas Bd Buy
PUT
$1.86 Million
621
Q3 2025
New holding
Aeva Technologies Inc
CALL
$1.25 Million
20
Q3 2025
New holding
Travere Therapeutics Inc
PUT
$390,000
1
Q3 2025
New holding
Jazz Pharmaceuticals PLC
PUT
$2.36 Million
115
Q3 2025
New holding
Ishares Tr
PUT
$5.1 Million
60
Q3 2025
Reduced 53.13%
Ready Capital Corp
CALL
$6.59 Million
527
Q3 2025
New holding
Applied Therapeutics Inc
CALL
$1.09 Million
44
Q3 2025
New holding
Eli Lilly & CO
PUT
$1.85 Million
23
Q3 2025
Reduced 99.93%
Mereo Biopharma Group PLC
PUT
$6.81 Million
91
Q3 2025
Reduced 96.05%
Aurinia Pharmaceuticals Inc
PUT
$118,000
3
Q3 2025
New holding
Moderna Inc
CALL
$2.15 Million
249
Q2 2025
Added 85.82%
Moonlake Immunotherapeutics
CALL
$36,000
61
Q3 2025
New holding
Spdr S&P 500 ETF Tr
PUT
$6.14 Million
46
Q3 2025
New holding
C4 Therapeutics Inc
CALL
$3.25 Million
325
Q3 2025
New holding
Harmony Biosciences Hldgs In
CALL
$3,000
345
Q3 2025
New holding
Cassava Sciences Inc
PUT
$984,000
24
Q3 2025
Reduced 99.97%
Agnc Invt Corp
CALL
$6.39 Million
1.62K
Q3 2025
New holding
Atyr Pharma Inc
CALL
$436,000
297
Q2 2025
Added 135.71%
Kodiak Sciences Inc
PUT
$145,000
3
Q3 2025
New holding

Summary

  • Portfolio
  • No. of Stocks 287
  • Current Value $145 Billion
  • Prior Value $135 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 10, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 84 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 39 stocks
Track This Portfolio

Track Persistent Asset Partners LTD Portfolio

Follow Persistent Asset Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persistent Asset Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Persistent Asset Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email